Summary
Hamster cells transformed with the Schmidt-Ruppin strain of avian sarcoma virus were selected for resistance to 5-bromodeoxyuridine (BUDR). The resistant cell lines Ha(SR)BU-25 and Ha(SR)BU-100, proliferated in the presence of 25 and 100 μg/ml BUDR, respectively. The resistant cells were deficient in thymidine kinase activity. They did not grow in HATG medium and did not incorporate labelled thymidine into DNA.
Several single-cell clones were isolated in medium containing 100 μg/ml BUDR from Ha(SR)BU-100 cells. These isolated cell clones differed in morphology and modal number of chromosomes from each other. None of the clones incorporated thymidine into DNA.
The BUDR resistant cells were tested for their tumorigenicity in young hamsters. The number of cells needed for induction of tumor growth was higher with the BUDR resistant cells than with original clone of Ha(SR) cells.
All clones of thymidine kinase deficient cells were tested for the presence of the virus genome by fusion with chicken embryo cells. All clones of Ha(SR)BU-100 cells contained the virus genome, and infectious virus could be rescued from these cells.
Therefore, the genome of avian sarcoma virus can persist in virogenic hamster cells growing in the presence of 5-bromodeoxyuridine. These virogenic cells deficient in thymidine kinase activity are useful for preparation of cell hybrids.
Similar content being viewed by others
References
Altanerova, V.: Induction of virus production by various chemical carcinogens in virogenic hamster cell line transformed by Rous sarcoma virus. J. nat. Cancer Inst.49, 1375–1380 (1972).
Altanerova, V., andC. Altaner: Characterization of chicken sarcoma viruses induced with chemical carcinogens and mutagens in transformed hamster cells. Neoplasma19, 405–412 (1972).
Altaner, C., and E.Hlavayova: Transformation of rat liver cells with chicken sarcoma virus B 77 and murine sarcoma virus. J. Virol.11, (1973).
Altaner, C., andF. Svec: Virus production in rat tumors induced by chicken sarcoma virus. J. nat. Cancer Inst.37, 745–752 (1966).
Altaner, C., andH. M. Temin: Carcinogenesis by RNA sarcoma viruses XII. A quantitative study of infection of rat cells in vitro by avian sarcoma viruses. Virology40, 118–134 (1970).
Altaner, C., E. Hlavayova, M. Hladka, andF. Svec: Clonal analysis of RBI rat tumor cells producing chicken sarcoma virus. Neoplasma19, 385–395 (1972).
Bader, J. P., andA. V. Bader: Evidence for a DNA replicative genome for RNA-containing tumor viruses. Proc. nat. Acad. Sci. (Wash.)67, 843–850 (1970).
Barski, G., S. Sorieul, andF. Cornefert: Formation of hybrid cells in combined cultures of two different mammalian cell strains. J. nat. Cancer Inst.26, 1269–1291 (1961).
Boettiger, D., andH. M. Temin: Light inactivation of focus formation by chicken embryo fibroblasts infected with avian sarcoma virus in the presence of 5-bromodeoxyuridine. Nature (Lond.)228, 622–624 (1970).
Burton, K.: A study of the conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J.62, 315–323 (1956).
Dubbs, D. R., andS. Kit: Effect of prolonged cultivation of SV-40 transformed mouse cells in bromodeoxyuridine or pretreatment with mitomycin C on rescue of SV-40. Int. J. Cancer6, 223–233 (1970).
Dubbs, D. R., S. Kit, R. A. de Torres, andM. Anken: Virogenic properties of bromodeoxyuridine-sensitive and bromodeoxyuridine-resistant simian virus 40 transformed mouse kidney cells. J. Virol.1, 968–979 (1967).
Fox, M., andJ. M. Zeiss: Chromosome preparation from fresh and cultured tissues using a modification of the drying technique. Nature (Lond.)192, 1213 to 1214 (1961).
Harris, H., andJ. F. Watkins: Hybrid cells derived from mouse and man: Artificial heterokaryons of mammalian cells from different species. Nature (Lond.)205, 640–646 (1965).
Kit, S., D. R. Dubbs, andP. M. Frearson: HeLa cells resistant to bromodeoxyuridine and deficient in thymidine kinase activity. Int. J. Cancer1, 19–30 (1966).
Kit, S., D. R. Dubbs, L. J. Piekarski, andT. C. Hsu: Deletion of thymidine kinase activity from L-cells resistant to bromodeoxyuridine. Exp. Cell Res.31, 297–312 (1963).
Littlefield, J. W.: Studies on thymidine kinase in cultured mouse fibroblasts. Biochim. biophys. Acta (Amst.)95, 14–22 (1965).
Littlefield, J. W., andP. F. Sarkar: Mouse fibroblast partially deficient in thymidine kinase. Fed. Proc.23, 169 (1964).
Lowy, D. R., W. P. Rowe, N. Teich, andJ. W. Hartley: Murine leukemia virus: High frequency activationin vitro by 5-iododeoxyuridine and 5-bromodeoxyuridine. Science174, 155–156 (1971).
Macpherson, I.: Reversion in hamster cells transformed by Rous sarcoma virus. Science148, 1731–1733 (1965).
Rabinowitz, Z., andL. Sachs: Reversion of properties in cells transformed by polyoma virus. Nature (Lond.)220, 1203–1206 (1968).
Reed, L. J., andH. Muench: A simple method of estimating fifty per cent endpoints. Amer. J. Hyg.27, 493–497 (1938).
Rowe, W. P., J. W. Hartley, M. R. Lander, W. R. Pugh, andN. Teich: Noninfectious AKR mouse embryo cell lines in which each cell has the capacity to be activated to produce infectious murine leukemia virus. Virology46, 866–876 (1971).
Rothschild, H., andP. H. Black: Effect of loss of thymidine kinase activity on the tumorigenicity of clones of SV 40-transformed hamster cells. Proc. nat. Acad. Sci. (Wash.)67, 1042–1049 (1970).
Temin, H. M.: Mechanism of cell transformation by RNA tumor viruses. Ann. Rev. Microbiol.25, 609–648 (1971).
Temin, H. M., andMizutani, S.: RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature (Lond.)226, 1211–1213 (1970).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Altaner, C., Hladka, M. & Schlechte, H. Avian sarcoma virus transformed hamster cells resistant to bromodeoxyuridine and deficient in thymidine kinase activity. Archiv f Virusforschung 41, 40–51 (1973). https://doi.org/10.1007/BF01249927
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01249927